Tharimmune Inc (THAR)
4.745
+0.26
(+5.69%)
USD |
NASDAQ |
May 31, 16:00
4.65
-0.10
(-2.01%)
After-Hours: 20:00
Tharimmune Enterprise Value: -4.697M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -4.697M |
| May 30, 2024 | -4.898M |
| May 29, 2024 | -4.623M |
| May 28, 2024 | -4.835M |
| May 24, 2024 | -4.832M |
| May 23, 2024 | -4.567M |
| May 22, 2024 | -4.584M |
| May 21, 2024 | -3.823M |
| May 20, 2024 | -3.994M |
| May 17, 2024 | -4.171M |
| May 16, 2024 | -4.085M |
| May 15, 2024 | -4.166M |
| May 14, 2024 | -4.129M |
| May 13, 2024 | -4.053M |
| May 10, 2024 | -3.993M |
| May 09, 2024 | -3.592M |
| May 08, 2024 | -3.599M |
| May 07, 2024 | -4.063M |
| May 06, 2024 | -4.089M |
| May 03, 2024 | -3.975M |
| May 02, 2024 | -3.977M |
| May 01, 2024 | -4.006M |
| April 30, 2024 | -4.146M |
| April 29, 2024 | -4.159M |
| April 26, 2024 | -4.076M |
| Date | Value |
|---|---|
| April 25, 2024 | -4.170M |
| April 24, 2024 | -4.041M |
| April 23, 2024 | -3.959M |
| April 22, 2024 | -4.060M |
| April 19, 2024 | -3.982M |
| April 18, 2024 | -3.973M |
| April 17, 2024 | -4.089M |
| April 16, 2024 | -4.091M |
| April 15, 2024 | -4.170M |
| April 12, 2024 | -3.893M |
| April 11, 2024 | -3.558M |
| April 10, 2024 | -3.476M |
| April 09, 2024 | -3.476M |
| April 08, 2024 | -3.244M |
| April 05, 2024 | -3.167M |
| April 04, 2024 | -3.028M |
| April 03, 2024 | -3.192M |
| April 02, 2024 | -2.941M |
| April 01, 2024 | -2.945M |
| March 28, 2024 | -5.863M |
| March 27, 2024 | -5.830M |
| March 26, 2024 | -5.863M |
| March 25, 2024 | -5.748M |
| March 22, 2024 | -5.808M |
| March 21, 2024 | -5.718M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-6.768M
Minimum
Mar 15 2024
48.29M
Maximum
Feb 02 2022
3.146M
Average
0.6033M
Median
Oct 04 2023
Enterprise Value Benchmarks
| Ironwood Pharmaceuticals Inc | 1.553B |
| Mirum Pharmaceuticals Inc | 1.138B |
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.256M |
| Total Expenses (Quarterly) | 2.347M |
| EPS Diluted (Quarterly) | -2.85 |
| Earnings Yield | -2.26K% |